Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Ultrafiltration, Ultracentrifugation), By Product & Services (Instrument), By End Use (CROs), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Prosthetic Liners Market Growth & Trends
The global prosthetic liners market size is expected to reach USD 299.9 million by 2030, registering a CAGR of 6.6% during the forecast period, according to a new report by Grand View Research, Inc. Rising prevalence of osteoarthritis, orthopedic injuries and other extremities that require prosthetics is expected to drive the product demand.
In addition, a paradigm shift toward cost-effective and durable materials used in prosthetic procedures is anticipated to fuel the market growth. Rise in road traffic accidents and sports injuries can be attributed to the growing demand for prosthetic procedures. This factor is projected to drive the demand for prosthetic liners over the forecast period.
Strategic initiatives such as technologically advanced product launch, mergers & acquisitions, and collaborative agreements are adopted by the market participants to gain greater market share. For instance, in July 2018, Blatchford announced the launch of Orion3 programming app for clinicians via Bluetooth for enabling faster and straight forward limb setup available on iOS. This innovative app provides reliable connectivity. Such initiatives are expected to boost the growth of the prosthetic liners market over the forecast period.
Prosthetic Liners Market Report Highlights
Prosthetic Liners Market Growth & Trends
The global prosthetic liners market size is expected to reach USD 299.9 million by 2030, registering a CAGR of 6.6% during the forecast period, according to a new report by Grand View Research, Inc. Rising prevalence of osteoarthritis, orthopedic injuries and other extremities that require prosthetics is expected to drive the product demand.
In addition, a paradigm shift toward cost-effective and durable materials used in prosthetic procedures is anticipated to fuel the market growth. Rise in road traffic accidents and sports injuries can be attributed to the growing demand for prosthetic procedures. This factor is projected to drive the demand for prosthetic liners over the forecast period.
Strategic initiatives such as technologically advanced product launch, mergers & acquisitions, and collaborative agreements are adopted by the market participants to gain greater market share. For instance, in July 2018, Blatchford announced the launch of Orion3 programming app for clinicians via Bluetooth for enabling faster and straight forward limb setup available on iOS. This innovative app provides reliable connectivity. Such initiatives are expected to boost the growth of the prosthetic liners market over the forecast period.
Prosthetic Liners Market Report Highlights
- Silicone material is the most preferred material for prosthetic liner manufacturing and hence accounted for the largest market share in terms of revenue in 2023.
- Upper extremity led the prosthetic liners market in 2023, owing to rising application of the product as they offer rapid and painless recovery. It also helps regain normal functioning of the affected area within a short period. Major companies manufacturing this product are Zimmer Biomet Holdings Inc.; Blatchford Inc., and Цssur.
- Hospitals accounted for the largest revenue share in 2023 due to the availability of highly skilled professionals and an increasing number of orthopedic surgeries performed in these settings.
- North America registered the dominant market share in 2023, due to the presence of a large number of industry players and supportive government initiatives.
- Asia Pacific is expected to witness the fastest CAGR over the forecast period owing to increasing number of target population and awareness among prosthetists regarding the benefits of liners for better health outcomes.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PROTEIN BINDING ASSAY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Protein Binding Assay Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining Power of the Suppliers
3.4.1.2. Bargaining Power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats From New Entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
CHAPTER 4. PROTEIN BINDING ASSAY MARKET: PRODUCT & SERVICES ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Protein Binding Assay Market: Product & Services Movement Analysis, 2023 & 2030 (USD Million)
4.3. Instrument
4.3.1. Instrument Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Kits & Reagents
4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PROTEIN BINDING ASSAY MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Protein Binding Assay Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
5.3. Ultracentrifugation
5.3.1. Ultracentrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Equilibrium Dialysis
5.4.1. Equilibrium Dialysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Ultrafiltration
5.5.1. Ultrafiltration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Surface Plasmon Resonance
5.6.1. Surface Plasmon Resonance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PROTEIN BINDING ASSAY MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Protein Binding Assay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Contract Research Organizations
6.3.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. PROTEIN BINDING ASSAY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Protein Binding Assay Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Italy Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Norway
7.3.7.1. Norway Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Denmark Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Sweden Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Kuwait
7.6.4.1. Kuwait Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. South Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Thermo Fisher Scientific
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. ADMEcell, Inc
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Beckman Coulter, Inc
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Sartorius Stedim BioOutsource Limited
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Bio-Rad Laboratories, Inc
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Abzena Ltd
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Abcam Plc
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. GVK Biosciences Private Limited
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Promega Corporation
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Arryait Corporation
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. Charles River Laboratories
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. Sovicell
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives
8.4.13. Eurofins Scientific
8.4.13.1. Participant’s Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Recent Developments/ Strategic Initiatives
8.4.14. 3B Pharmaceuticals
8.4.14.1. Participant’s Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Recent Developments/ Strategic Initiatives
8.4.15. Creative Biolabs
8.4.15.1. Participant’s Overview
8.4.15.2. Financial Performance
8.4.15.3. Product Benchmarking
8.4.15.4. Recent Developments/ Strategic Initiatives
8.4.16. Evotec SE
8.4.16.1. Participant’s Overview
8.4.16.2. Financial Performance
8.4.16.3. Product Benchmarking
8.4.16.4. Recent Developments/ Strategic Initiatives
8.4.17. BioDuro-Sundia
8.4.17.1. Participant’s Overview
8.4.17.2. Financial Performance
8.4.17.3. Product Benchmarking
8.4.17.4. Recent Developments/ Strategic Initiatives
8.4.18. Merck KGaA
8.4.18.1. Participant’s Overview
8.4.18.2. Financial Performance
8.4.18.3. Product Benchmarking
8.4.18.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. PROTEIN BINDING ASSAY MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Protein Binding Assay Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining Power of the Suppliers
3.4.1.2. Bargaining Power of the Buyers
3.4.1.3. Threats of Substitution
3.4.1.4. Threats From New Entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
CHAPTER 4. PROTEIN BINDING ASSAY MARKET: PRODUCT & SERVICES ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Protein Binding Assay Market: Product & Services Movement Analysis, 2023 & 2030 (USD Million)
4.3. Instrument
4.3.1. Instrument Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Kits & Reagents
4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Services
4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. PROTEIN BINDING ASSAY MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Protein Binding Assay Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
5.3. Ultracentrifugation
5.3.1. Ultracentrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Equilibrium Dialysis
5.4.1. Equilibrium Dialysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Ultrafiltration
5.5.1. Ultrafiltration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Surface Plasmon Resonance
5.6.1. Surface Plasmon Resonance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. PROTEIN BINDING ASSAY MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Protein Binding Assay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Contract Research Organizations
6.3.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Pharmaceutical & Biotechnology Companies
6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. PROTEIN BINDING ASSAY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Protein Binding Assay Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
7.2.1. North America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Italy Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Norway
7.3.7.1. Norway Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Denmark Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Sweden Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Kuwait
7.6.4.1. Kuwait Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. South Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Thermo Fisher Scientific
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. ADMEcell, Inc
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Beckman Coulter, Inc
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Sartorius Stedim BioOutsource Limited
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Bio-Rad Laboratories, Inc
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Abzena Ltd
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Abcam Plc
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. GVK Biosciences Private Limited
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Promega Corporation
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Arryait Corporation
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
8.4.11. Charles River Laboratories
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/ Strategic Initiatives
8.4.12. Sovicell
8.4.12.1. Participant’s Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Recent Developments/ Strategic Initiatives
8.4.13. Eurofins Scientific
8.4.13.1. Participant’s Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Recent Developments/ Strategic Initiatives
8.4.14. 3B Pharmaceuticals
8.4.14.1. Participant’s Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Recent Developments/ Strategic Initiatives
8.4.15. Creative Biolabs
8.4.15.1. Participant’s Overview
8.4.15.2. Financial Performance
8.4.15.3. Product Benchmarking
8.4.15.4. Recent Developments/ Strategic Initiatives
8.4.16. Evotec SE
8.4.16.1. Participant’s Overview
8.4.16.2. Financial Performance
8.4.16.3. Product Benchmarking
8.4.16.4. Recent Developments/ Strategic Initiatives
8.4.17. BioDuro-Sundia
8.4.17.1. Participant’s Overview
8.4.17.2. Financial Performance
8.4.17.3. Product Benchmarking
8.4.17.4. Recent Developments/ Strategic Initiatives
8.4.18. Merck KGaA
8.4.18.1. Participant’s Overview
8.4.18.2. Financial Performance
8.4.18.3. Product Benchmarking
8.4.18.4. Recent Developments/ Strategic Initiatives
